SCHEMBL8789976

SCHEMBL8789976

COc1ccc2[nH]c3c(C(=O)O)cccc3c(=O)c2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PBRM1 Q86U86 2/20 0.64
ABCG2 Q9UNQ0 4/20 0.60
ALDH1A1 P00352 6/20 0.60
KDM4E B2RXH2 5/20 0.60
POLB P06746 2/20 0.60
GAA P10253 2/20 0.60
TDP1 Q9NUW8 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
STING1 Q86WV6 1/20 0.57
ROCK2 O75116 1/20 0.48
CTSV O60911 1/20 0.48
CTSL P07711 1/20 0.48
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
HPGD P15428 3/20 0.48
MAPT P10636 2/20 0.48
HSD17B10 Q99714 2/20 0.48
PDGFRB P09619 1/20 0.47
TSHR P16473 1/20 0.46
GFER P55789 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11733627 0.91 KDM4E (0.60) PBRM1ABCG2ALDH1A1KDM4EPOLB
SCHEMBL8790759 0.81 PBRM1 (0.52) PBRM1ABCG2ALDH1A1KDM4EPOLB
SCHEMBL9601051 0.80 ABCG2 (0.65) ABCG2ALDH1A1KDM4EPOLBGAA
SCHEMBL7568234 0.80 PBRM1 (0.69) PBRM1ALDH1A1KDM4EPOLBGAA
SCHEMBL7564762 0.80 PBRM1 (0.69) PBRM1KDM4EPOLBTDP1MEN1
SCHEMBL2440948 0.80 PBRM1 (0.69) PBRM1ABCG2KDM4EPOLBGAA
SCHEMBL8132211 0.80 PBRM1 (0.52) PBRM1ABCG2ALDH1A1KDM4EPOLB
SCHEMBL7567402 0.80 PBRM1 (0.64) PBRM1ABCG2ALDH1A1KDM4E
SCHEMBL7565942 0.80 PBRM1 (0.64) PBRM1ABCG2KDM4EGAATDP1
SCHEMBL8789035 0.80 PBRM1 (0.64) PBRM1ABCG2ALDH1A1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0569380-B1 ACRIDINE DERIVATIVES GLAXO LAB SA (FR) 1997-05-28 EP disclosed
US-5604237-A IMPROVE OR INCREASE EFFICACY OF ANTITUMOR AGENT, INCREASE OR RESTORE SENSITIVITY OF TUMOR TO ANTITUMOR AGENT, REVERSE OR REDUCE RESISTANCE OF TUMOR TO ANTITUMOR AGENT LABORATOIRES GLAXO SA (FR) 1997-02-18 US disclosed
EP-0569380-A1 ACRIDINE DERIVATIVES. GLAXO LAB SA (FR) 1993-11-18 EP disclosed
WO-1992012132-A1 ACRIDINE DERIVATIVES LABORATOIRES GLAXO S.A. (FR) 1992-07-23 WO disclosed
EP-0494623-A1 Acridine derivatives LABORATOIRES GLAXO SA (FR) 1992-07-15 EP disclosed